Guidelines on the management of Waldenström macroglobulinaemia*
- 13 February 2006
- journal article
- practice guideline
- Published by Wiley in British Journal of Haematology
- Vol. 132 (6), 683-697
- https://doi.org/10.1111/j.1365-2141.2005.05948.x
Abstract
No abstract availableThis publication has 101 references indexed in Scilit:
- IgM myeloma with t(4;14)(p16;q32)Cancer Genetics and Cytogenetics, 2005
- Initial immunoglobulin M ‘flare’ after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemiaCancer, 2004
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003
- Treatment of IgM antibody associated polyneuropathies using rituximabJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 casesBritish Journal of Haematology, 2001
- Autologous peripheral blood stem cell transplantation for Waldenstrom’s macroglobulinemiaBone Marrow Transplantation, 1999
- Allogeneic bone marrow transplantation for advanced Waldenstrom’s macroglobulinemiaBone Marrow Transplantation, 1999
- Waldenström's Macroglobulinemia: Long-Term Results with the M-2 ProtocolCancer Investigation, 1991
- Plasmapheresis in Hyperviscosity SyndromeActa Medica Scandinavica, 1985
- Bone Marrow Histology in Waldenström's MacroglobulinaemiaScandinavian Journal of Haematology, 1983